Postpartum depression
Postpartum depression refers to depression symptoms that occur after childbirth. It is the most common type of postpartum mental syndrome. The mother is irritable, fearful, anxious, depressed, and overly worried about her own and her baby's health. She often loses the ability to take care of herself and her baby, and sometimes falls into a state of confusion or lethargy.
-
Site of disease:
Psychological Female Reproduction -
Infectious :
Not contagious -
Frequent population:
The disease usually occurs 2 weeks after delivery, 4 to 6 weeks after delivery... -
Related symptoms:
Extreme postpartum behavior anxiety worrying about the spleen no milk secretion after childbirth depression -
Concurrent disease:
Related Drugs
Anle tablets
Manufacturer:
Shanghai Diran Dancheng Pharmaceutical Co., Ltd.
ZULRESSO- brexanolone_injection, solution
Indication: ZULRESSO is indicated for the treatment of postpartum depression (PPD) in patients 15 years and older [see Clinical Studies ( 14 ZULRESSO is a neuroactive steroid gamma-aminobutyric acid (GABA) A receptor positive modulator indicated for the treatment of postpartum depression (PPD) in patients 15 years and older.
Manufacturer:
Sage Therapeutics, Inc.
Related Ingredients
-
Riligustilide list
89354-45-0 -
Magnesium stearate list
557-04-0